Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 9, 2011 - Issue 9
Submit an article Journal homepage
83
Views
1
CrossRef citations to date
0
Altmetric
Special Report

Candesartan cilexetil in the management of blood pressure for acute and recurrent stroke in Japan: the Challenge-Stroke study

Norio Tanahashi Department of Neurology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama 350-1298, Japan. [email protected]; Department of Neurology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama 350-1298, Japan. [email protected]
,
Jyoji Nakagawara Department of Neurosurgery and Stroke Center, Nakamura Memorial Hospital, Hokkaido, Japan; Department of Neurosurgery and Stroke Center, Nakamura Memorial Hospital, Hokkaido, Japan
,
Yasushi Okada Department of Cerebrovascular Medicine and Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan; Department of Cerebrovascular Medicine and Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan
,
Kazuo Minematsu National Cerebral and Cardiovascular Center, Osaka, Japan; National Cerebral and Cardiovascular Center, Osaka, Japan
& The Challenge-Stroke Study Group
Pages 1115-1126 | Published online: 10 Jan 2014

References

  • Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet367(9524), 1747–1757 (2006).
  • Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol.6(2), 182–187 (2007).
  • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet360(9349), 1903–1913 (2002).
  • Chalmers J, Todd A, Chapman N et al.; International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention. J. Hypertens.21(4), 651–663 (2003).
  • Donnan GA, Davis SM, Thrift A. The role of blood pressure lowering before and after stroke. Curr. Opin. Neurol.16(1), 81–86 (2003).
  • Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke34(11), 2741–2748 (2003).
  • Spengos K, Tsivgoulis G, Zakopoulos N. Blood pressure management in acute stroke: a long-standing debate. Eur. Neurol.55(3), 123–135 (2006).
  • Tikhonoff V, Zhang H, Richart T, Staessen JA. Blood pressure as a prognostic factor after acute stroke. Lancet Neurol.8(10), 938–948 (2009).
  • Aiyagari V, Gorelick PB. Management of blood pressure for acute and recurrent stroke. Stroke.40(6), 2251–2256 (2009).
  • Potter JF, Robinson TG, Ford GA et al. Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol.8(1), 48–56 (2009).
  • Anderson CS, Huang Y, Arima H et al.; INTERACT Investigators. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke41(2), 307–312 (2010).
  • Robinson TG, Potter JF, Ford GA et al.; COSSACS Investigators. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol.9(8), 767–775 (2010).
  • Sandset EC, Bath PM, Boysen G et al.; SCAST Study Group. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet377(9767), 741–750 (2011).
  • Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation118(2), 176–187 (2008).
  • Bath P, Chalmers J, Powers W et al. International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J. Hypertens.21(4), 665–672 (2003).
  • Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA; IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke33(5), 1315–1320 (2002).
  • Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension43(1), 18–24 (2004).
  • JSH Working Group for Preparation of Guidelines for the Management of Hypertension. JSH Guidelines for the Management of Hypertension 2004. Life Science, Tokyo, Japan (2004).
  • Joint Working Group for Preparation of Guidelines for the Management of Stoke. Japanese Guideline for the Management of Stroke 2004. Kyowa Kikaku Tokyo, Tokyo, Japan (2004).
  • Schrader J, Lüders S, Kulschewski A et al.; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke34(7), 1699–1703 (2003).
  • JSH Working Group for Preparation of Guidelines for the Management of Hypertension. JSH Guidelines for the Management of Hypertension 2009. Life Science, Tokyo, Japan (2009).
  • Joint Working Group for Preparation of Guidelines for the Management of Stoke. Japanese Guideline for the Management of Stroke 2009. Kyowa Kikaku Tokyo, Tokyo, Japan (2009).
  • Koga M, Toyoda K, Naganuma M et al.; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) study investigators. Nationwide survey of antihypertensive treatment for acute intracerebral hemorrhage in Japan. Hypertens. Res.32(9), 759–764 (2009).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.